Back to search

Article

Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker in prostate cancer patients

2022-08-10

Abstract excerpt

<h4>Purpose: </h4> To explore the mechanisms that affect the radiosensitivity of prostate cancer and to search for radiotherapy outcome-related prognostic markers in prostate cancer patients through bioinformatics analysis. Methods The cancer cell data set GSE192817 and TCGA PRAD data set were downloaded from GEO database and UCSC Xena database for differential analysis, and biological function analysis of differ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
979e9823-6ba3-502d-99c0-f205baa5a339
DOI
10.21203/rs.3.rs-1935488/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker in prostate cancer patientsDOI 10.21203/rs.3.rs-1935488/v1
Select a neighboring publication to make it the new centre.